We use various microbiology techniques (including metabolomics, metagenomics, transcriptomics, molecular imaging), in vitro (organ culture, organoids, cell culture) and animal models to characterize disease pathophysiology and to identify potential targets for disease mitigation (e.g. alternatives to antibiotics, vaccines). We use this knowledge to deliver solutions applicable at the field, in farms and wherever else it is necessary.

While intestinal diseases are our core focus, we collaborate with other groups studying other organs and species (including humans!).